A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients

PURPOSE: Amrubicin is one of the most active chemotherapeutic drugs for small cell lung cancer (SCLC). Previous studies reported its effectiveness and severe hematological toxicity. However, the efficacy of amrubicin monotherapy in elderly patients with SCLC has not been described. The objective of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Chemother Pharmacol
Autors principals: Imai, Hisao, Sugiyama, Tomohide, Tamura, Tomohiro, Minemura, Hiroyuki, Kaira, Kyoichi, Kanazawa, Kenya, Yokouchi, Hiroshi, Kasai, Takashi, Kaburagi, Takayuki, Minato, Koichi
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5573757/
https://ncbi.nlm.nih.gov/pubmed/28761968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-017-3403-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars